High Flow Nasal Oxygenation vs Endotracheal Intubation on Recovery Profiles in Laryngeal Microsurgery

Launched by AJOU UNIVERSITY SCHOOL OF MEDICINE · Sep 26, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to provide oxygen to patients undergoing a specific type of throat surgery called laryngeal microsurgery. The researchers want to see if using a method called high-flow nasal oxygen (HFNO), which delivers warm and humidified oxygen through the nose, can help reduce coughing when patients wake up from anesthesia compared to using a breathing tube (endotracheal intubation). Coughing during recovery can be uncomfortable and may affect healing, so this study aims to find out which method is better for patients.

To participate in this trial, patients should be between the ages of 18 and 65 and classified as healthy or slightly unhealthy by anesthesia standards (levels 1 or 2). However, those with serious heart, lung, or brain diseases, as well as those who are very overweight or undergoing certain types of laser surgery, will not be eligible. Participants can expect to receive either the high-flow nasal oxygen or the breathing tube method during their surgery and will be monitored closely afterward to see how well they recover. This study is currently recruiting participants, and it could help improve recovery experiences for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with American Society of Anesthesiologists classification 1 or 2 who receive general anesthesia for laryngeal microsurgery
• Exclusion Criteria:
• • Patients with major cardiovascular, pulmonary, and cerebrovascular disease
• • Laser laryngeal surgery
• • Morbid obesity (BMI\>35 kg/m2)